EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

HYPOTHESIS OF MEDICINAL AND PHARMACEUTICAL COMPOUND (GRAIN OF NIGELLA SATIVA)

Dr.Meena Chourey, Shipra Gupta, Anamika Satanker, Niketan Mishra, Nikhil Kumar Sharma, Nikunj Choudhary

Genetics and Molecular Research · 04.11.2026

DOI: 10.4238/rkqrat96 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetics and Molecular Research, online erschienen am 04.11.2026. Verfasst von Dr.Meena Chourey und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nigella sativa (black seed) has long been recognized in traditional medicinal systems for its broad therapeutic potential. This study presents a scientific hypothesis that the grains of Nigella sativa contain pharmaceutically significant bioactive compounds capable of exerting multi-targeted medicinal effects. The hypothesis is based on the presence of key constituents such as thymoquinone, alkaloids, saponins, flavonoids, and essential fatty acids, which are proposed to act synergistically to produce antioxidant, anti-inflammatory, antimicrobial, immunomodulatory, and anticancer activities. It is hypothesized that these compounds influence critical biochemical pathways by reducing oxidative stress, modulating inflammatory mediators, enhancing immune responses, and regulating cellular proliferation and apoptosis. Furthermore, the hypothesis suggests that advanced pharmaceutical formulations, including nano-based and controlled-release systems, may significantly improve the bioavailability and therapeutic efficiency of Nigella sativa–derived compounds. Validation of this hypothesis through systematic in vitro, in vivo, and clinical studies could facilitate the development of novel, safe, and cost-effective herbal-based pharmaceutical products. This hypothesis-driven approach supports the potential integration of Nigella sativa grain compounds into modern medicinal and pharmaceutical applications. The grains of Nigella sativa (2.0 kg) were extracted with n-hexane using a Sox let extractor for a period of 5–6 days. After approximately 120 hours, the solvent was removed using a distillation apparatus, followed by evaporation and concentration of the extract. The resulting n-hexane extract yielded about 150 g of a dark yellow unsaponifiable fraction. This fraction consisted of substances associated with oils and fats that are not hydrolyzed during saponification. The unsaponifiable matter was analyzed by thin-layer chromatography (TLC), which revealed the presence of six to seven distinct compounds. Further separation of the extract was achieved using column chromatography. The isolated compounds were characterized using IR, ¹H NMR, ¹³C NMR, and mass spectroscopic techniques. The plant extract exhibited various biological activities, including ant fertility, analgesic, anticestodal, antibacterial, post-coital anti-implantation, and antifeedant activities. Nigella sativa, commonly known as Kalonji or black onion seed, is a spicy medicinal plant. Taxonomically, it belongs to Angiospermae, Dicotyledonae, Polypetalous, Thalami florae, Order Ranales, and Family Ranunculaceae..

Zitieren

APA

Chourey, D., Gupta, S., Satanker, A., Mishra, N., Sharma, N. K., & Choudhary, N. (2026). HYPOTHESIS OF MEDICINAL AND PHARMACEUTICAL COMPOUND (GRAIN OF NIGELLA SATIVA). Genetics and Molecular Research. https://doi.org/10.4238/rkqrat96

Vancouver

Chourey D, Gupta S, Satanker A, Mishra N, Sharma NK, Choudhary N. HYPOTHESIS OF MEDICINAL AND PHARMACEUTICAL COMPOUND (GRAIN OF NIGELLA SATIVA). Genetics and Molecular Research. 2026. doi:10.4238/rkqrat96

BibTeX
@article{Chourey2026,
  author = {Chourey, Dr.Meena and Gupta, Shipra and Satanker, Anamika and Mishra, Niketan and Sharma, Nikhil Kumar and Choudhary, Nikunj},
  title = {HYPOTHESIS OF MEDICINAL AND PHARMACEUTICAL COMPOUND (GRAIN OF NIGELLA SATIVA)},
  journal = {Genetics and Molecular Research},
  year = {2026},
  doi = {10.4238/rkqrat96}
}
Kostenlos starten →